BioInvent International AB (publ) BOVNF 上一季度的收入表现如何?
BioInvent International AB (publ) 的收入预期是多少?
BioInvent International AB (publ) 的盈利质量评分是多少?
BioInvent International AB (publ) 何时发布财报?
BioInvent International AB (publ) 的预期收益是多少?
BioInvent International AB (publ) 是否超出收益预期?
关键数据
前收盘价
$3.28
开盘价
$4.7
当日区间
$3.28 - $4.7
52周范围
$3.28 - $4.7
交易量
908
平均成交量
0
每股收益(TTM)
-0.47
股息收益率
--
市值
$216.4M
什么是 BIOINVENT INTERNATIONAL AB?
BioInvent International AB is a clinical-stage biotech company that discovers and develops novel and immuno-modulatory antibodies for cancer therapy. The company is headquartered in Lund, Skane and currently employs 124 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.